Baidu
map

沉痛悼念著名肝脏病学家王宝恩

2014-10-12 MedSci MedSci原创

 我国著名肝脏病学家、肝纤维化研究泰斗、中华医学会肝病学分会创始人兼第一任主任委员、首都医科大学附属北京友谊医院名誉院长王宝恩教授,于2014年10月11日上午8点50分在北京友谊医院与世长辞,享年88岁。王宝恩先生致力于我国肝病学事业及中西医结合研究50余年,他治学严谨、德高医精,在国内外医学界享有高度赞誉。先生的离世是我国肝病学界的重大损失!   王宝恩先生生平   

 我国著名肝脏病学家、肝纤维化研究泰斗、中华医学会肝病学分会创始人兼第一任主任委员、首都医科大学附属北京友谊医院名誉院长王宝恩教授,于2014年10月11日上午8点50分在北京友谊医院与世长辞,享年88岁。王宝恩先生致力于我国肝病学事业及中西医结合研究50余年,他治学严谨、德高医精,在国内外医学界享有高度赞誉。先生的离世是我国肝病学界的重大损失!  

王宝恩先生生平

  

王宝恩,男,1926年2月生。1948年毕业于北京大学医学院。1952年起先后任北京友谊医院内科副主任、主任、院长、研究所所长、名誉院长。1978年起先后任首都医科大学内科学教授、临床二系主任,硕士生导师、博士生导师。1980年5月,受聘为美国约翰·霍普金斯大学医学院客座教授。曾担任中华医学会名誉理事、中华肝病名誉主委、中国中西医结合学会常务理事、中华医学会肝病学分会名誉主委、《中华肝脏病杂志》名誉主编,亚太肝病研究学会(APASL)、美国肝病研究学会(AASLD)及美国消化内镜学会(ASGE)会员。 

荣誉及成就

  王宝恩先生生平曾荣获国家级、部级奖7项,市级奖10项,局级奖14项,共30余项;发表论文100余篇,主编4部专著。2014年被评选为第二届国医大师。

  王宝恩先生为我国肝病学界带来了两项重大创新成就(1)运用现代医学及分子生物学研究方法,证明了中药在逆转肝纤维化及早期肝硬化中的作用,发明了抗肝纤维化中药--“复方861”,使肝硬化早期患者的肝纤维化逆转率达到75%~82%,取得了突出成就;(2)通过20多年临床实践,研究感染性多脏器衰竭的动态、分期诊断标准以及多脏器衰竭的中医证型、治则和方剂,提高了疾病抢救的成功率,使感染并发多脏器功能不全的病死率,从1985年以前的50%下降到90年代的26.9%,达到国际先进水平。

王宝恩先生为我国肝病学会的成立、发展及壮大做出了卓越贡献。1992年11月,在联合庄辉、田庚善、叶应妩、张定凤等老一辈肝病学家的积极筹备下,中华医学会肝病学分会成立。作为中华医学会肝病学分会第一任主任委员,王宝恩先生高瞻远瞩,为肝病学会的发展打下了坚实的基础。王宝恩先生借鉴国外学会的经验,于1993年中华医学会肝病学分会创办了《肝脏病杂志》,张定凤教授担任杂志主编。

对于王宝恩先生开展学会工作的理念,中华医学会肝病学分会第二任主任委员庄辉院士概括为两点:一是“有远见”。庄辉院士说,王宝恩教授构建肝病学会框架时充分考虑到多方需求,吸收了多学科专家,为肝病学会打下了坚实的基础,在此基础上,肝病学会的影响力越来越大。二是“注重学术交流”。上世纪90年代初期,中国医师能够出国参加国际会议、了解学科前沿进展的机会少之又少。肝病学分会自成立以来,曾单独或与兄弟学会合作,先后举办了多次大型国际和全国性肝病学术会议,这些会议大大推动了我国肝病的防治和研究工作,扩大了国际影响。

王宝恩教授主要学术论著

Yang AT, Wang P, Tong XF, Cong M, Liu TH, Cong R, Wu P, Jia JD, Wang BE, You H.Connective tissue growth factor induces hepatic progenitor cells to differentiate into hepatocytes. Int J Mol Med. 2013 Jul;32(1):35-42

Miao B, Zhang S, Wang H, Yang T, Zhou D, Wang BE.Magnolol pretreatment prevents sepsis-induced intestinal dysmotility by maintaining functional interstitial cells of Cajal. Inflammation. 2013 Aug;36(4):897-906

He Q, You H, Li XM, Liu TH, Wang P, Wang BE.HMGB1 promotes the synthesis of pro-IL-1β and pro-IL-18 by activation of p38 MAPK and NF-κB through receptors for advanced glycation end-products in macrophages. Asian Pac J Cancer Prev. 2012;13(4):1365-70.

Zhang YG, Wang BE, Wang TL, Ou XJ.Assessment of hepatic fibrosis by transient elastography in patients with chronic hepatitis B.Pathol Int. 2010 Apr;60(4):284-90

Liu C, Li A, Weng YB, Duan ML, Wang BE, Zhang SW.Changes in intestinal mucosal immune barrier in rats with endotoxemia. World J Gastroenterol. 2009 Dec 14;15(46):5843-50

Zhang L, Wang B.Randomized clinical trial with two doses (100 and 40 ml) of Stronger Neo-Minophagen C in Chinese patients with chronic hepatitis B. Hepatol Res. 2002 Nov;24(3):220.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=32541, encodeId=5822325417e, content=可惜!哀悼大师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Mon Jul 13 00:33:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808394, encodeId=76c018083941c, content=<a href='/topic/show?id=c54b8145698' target=_blank style='color:#2F92EE;'>#肝脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81456, encryptionId=c54b8145698, topicName=肝脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Mon Oct 27 11:06:00 CST 2014, time=2014-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495297, encodeId=c74c149529e97, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Mon Oct 13 15:06:00 CST 2014, time=2014-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12163, encodeId=bf0b1216392, content=沉痛哀悼这位大师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87d138660, createdName=wugerde, createdTime=Mon Oct 13 14:41:00 CST 2014, time=2014-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12164, encodeId=b88412164ec, content=沉痛哀悼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87d138660, createdName=wugerde, createdTime=Mon Oct 13 14:41:00 CST 2014, time=2014-10-13, status=1, ipAttribution=)]
    2015-07-13 1dd82894m82(暂无匿称)

    可惜!哀悼大师!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=32541, encodeId=5822325417e, content=可惜!哀悼大师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Mon Jul 13 00:33:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808394, encodeId=76c018083941c, content=<a href='/topic/show?id=c54b8145698' target=_blank style='color:#2F92EE;'>#肝脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81456, encryptionId=c54b8145698, topicName=肝脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Mon Oct 27 11:06:00 CST 2014, time=2014-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495297, encodeId=c74c149529e97, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Mon Oct 13 15:06:00 CST 2014, time=2014-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12163, encodeId=bf0b1216392, content=沉痛哀悼这位大师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87d138660, createdName=wugerde, createdTime=Mon Oct 13 14:41:00 CST 2014, time=2014-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12164, encodeId=b88412164ec, content=沉痛哀悼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87d138660, createdName=wugerde, createdTime=Mon Oct 13 14:41:00 CST 2014, time=2014-10-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=32541, encodeId=5822325417e, content=可惜!哀悼大师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Mon Jul 13 00:33:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808394, encodeId=76c018083941c, content=<a href='/topic/show?id=c54b8145698' target=_blank style='color:#2F92EE;'>#肝脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81456, encryptionId=c54b8145698, topicName=肝脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Mon Oct 27 11:06:00 CST 2014, time=2014-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495297, encodeId=c74c149529e97, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Mon Oct 13 15:06:00 CST 2014, time=2014-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12163, encodeId=bf0b1216392, content=沉痛哀悼这位大师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87d138660, createdName=wugerde, createdTime=Mon Oct 13 14:41:00 CST 2014, time=2014-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12164, encodeId=b88412164ec, content=沉痛哀悼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87d138660, createdName=wugerde, createdTime=Mon Oct 13 14:41:00 CST 2014, time=2014-10-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=32541, encodeId=5822325417e, content=可惜!哀悼大师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Mon Jul 13 00:33:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808394, encodeId=76c018083941c, content=<a href='/topic/show?id=c54b8145698' target=_blank style='color:#2F92EE;'>#肝脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81456, encryptionId=c54b8145698, topicName=肝脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Mon Oct 27 11:06:00 CST 2014, time=2014-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495297, encodeId=c74c149529e97, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Mon Oct 13 15:06:00 CST 2014, time=2014-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12163, encodeId=bf0b1216392, content=沉痛哀悼这位大师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87d138660, createdName=wugerde, createdTime=Mon Oct 13 14:41:00 CST 2014, time=2014-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12164, encodeId=b88412164ec, content=沉痛哀悼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87d138660, createdName=wugerde, createdTime=Mon Oct 13 14:41:00 CST 2014, time=2014-10-13, status=1, ipAttribution=)]
    2014-10-13 wugerde

    沉痛哀悼这位大师!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=32541, encodeId=5822325417e, content=可惜!哀悼大师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Mon Jul 13 00:33:00 CST 2015, time=2015-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808394, encodeId=76c018083941c, content=<a href='/topic/show?id=c54b8145698' target=_blank style='color:#2F92EE;'>#肝脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81456, encryptionId=c54b8145698, topicName=肝脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Mon Oct 27 11:06:00 CST 2014, time=2014-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495297, encodeId=c74c149529e97, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Mon Oct 13 15:06:00 CST 2014, time=2014-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12163, encodeId=bf0b1216392, content=沉痛哀悼这位大师!, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87d138660, createdName=wugerde, createdTime=Mon Oct 13 14:41:00 CST 2014, time=2014-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=12164, encodeId=b88412164ec, content=沉痛哀悼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87d138660, createdName=wugerde, createdTime=Mon Oct 13 14:41:00 CST 2014, time=2014-10-13, status=1, ipAttribution=)]
    2014-10-13 wugerde

    沉痛哀悼!

    0

相关资讯

Diabetes:过量饱和脂肪酸致肝脂肪蓄积

瑞典一项研究表明,在健康人群中,过量摄入饱和脂肪酸(SFA)可导致肝脏和内脏脂肪蓄积,过量摄入多不饱和脂肪酸(PUFA)则可促进无脂肪组织增加。论文于2月18日在线发表于《糖尿病》(Diabetes)杂志。【原文下载】 此项双盲、平行组、随机试验共纳入39例体重正常的青年受试者,并且受试者在7周期间过量摄入SFA(棕榈油)或PUFA(葵花籽油)高含量松饼。利用MRI评估肝脏脂肪、内脏脂肪(VAT

EASL 2014:肝脏弹性测定对酒精肝纤维化诊断价值高

FibroScan(肝脏弹性测定)是利用超声技术通过肝脏组织对低频超声震动波反射而来的弹性数值,来评估肝脏的硬度,具有无创、无痛、安全、快捷的优点。弹性数值单位以千帕(kPa)来表示,其数值越大,表示肝组织质地越硬,纤维化程度越严重。 使用Fibroscan对酒精性肝纤维化进行诊断其价值如何依然是有争议的。尤其对于4期肝纤维化(F4)的硬度诊断的临界值,转氨酶的升高或合并酒精性肝炎是否会对酒精性肝

AJR:LI-RADS——肝脏影像学报告和数据管理系统

LI-RADS的必要性肝细胞肝癌(HCC)可谓“恶名昭著”,在男性最常见的肿瘤和最常见的肿瘤死亡原因排行中,HCC分别位列第五位和第二位。现有治疗HCC的手段包括切除、局部治疗和肝移植,但无论是哪一种方式,无一例外都对早期HCC有效。因此,对于HCC而言,早期诊断和分期是决定治疗预后的关键因素。而且,与其他很多恶性肿瘤不同,对HCC的治疗决策常常只取决于影像学表现,而不依赖组织学检查。影像学检

PNAS:揭示病毒促使肝脏防御机制衰弱的分子机制

肝脏是机体中可以修改免疫反应的唯一器官,但是其又为强烈的免疫攻击提供了缺口,近日,来自悉尼大学的研究人员通过研究揭示了发生这一原因的分子机制,相关研究成果刊登于国际杂志PNAS上。相关研究为开发改善慢性肝炎的疗法提供了一定思路。 揭开这一谜题的关键是肝脏中免疫系统的T细胞,研究人员发现,当肝脏中的T细胞“遇到”一系列可以产生异体蛋白的细胞时,其就会以正常途径发挥功能,即刺激细胞的产生来遏制这

扁桃体干细胞或可用于肝脏损伤治疗

研究表明肝脏对身体来说具有非常重要的作用,比如它能清除身体毒素。缺少肝脏对人体来说是致命的,如果它受到损害,相对来说是很难治愈的。但是科学家们发表在ACS Applied Materials & Interfaces 杂志上的文章指出可以抽取扁桃体中的干细胞(这一部分是我们身体所不需要的)来修复受损肝脏器官,且全程无需动手术便可实施。 Byeongmoon Jeong 和他的同事们指

J Nutr:植物提取物木犀草素能够缓解酒精导致的肝脏损害

国际营养领域期刊Journal of Nutrition在线发表了营养所陈雁研究组的论文“Luteolin alleviates alcoholic liver disease induced by chronic and binge ethanol feeding in mice”,揭示了植物提取物木犀草素对酒精性肝脏损害的保护功能。  木犀草素(luteolin)广

Baidu
map
Baidu
map
Baidu
map